COCA Call – 2018-2019 Influenza Season and Recommendations for Clinicians

Calendar Reminder To Get A Flu ShotInfluenza activity in the United States is increasing and is expected to continue at elevated levels for several more weeks. Influenza A(H1N1)pdm09 viruses have been most common this season; influenza A(H3N2) and influenza B viruses are also circulating. In the southeastern part of the country, influenza A(H3N2) viruses have been most commonly reported this season. Annual influenza vaccination is recommended for all people 6 months and older and is the best way to prevent influenza and its potentially serious complications. Available evidence consistently indicates that antiviral treatment initiated as early as possible can be a useful second line of defense to treat influenza illness when indicated and can reduce severe outcomes of influenza.

During this CDC Clinician Outreach and Communication Activity (COCA) Call, clinicians will learn about 2018 –2019 influenza activity and hear an overview of CDC’s recommendations for health care providers regarding influenza vaccination and the use of influenza antiviral medications for the 2018-2019 influenza season, including a new antiviral medication approved by the FDA in October 2018. View complete info at:

Date: Tuesday, January 29, 2019
Time: 2:00-3:00 PM ET
A few minutes before the webinar begins, please click the link below to join the webinar:

Or iPhone one-tap:
US: +16468769923,,862187873#  or +16699006833, 862187873#

Or Telephone:
US: +1 646 876 9923  or +1 669 900 6833

Webinar ID: 862 187 873
International numbers available here:
The recordings (audio, slides, and transcript) for this call will be posted on the webpage a week after the COCA Call.
Free Continuing Education (CE) is available for most COCA Calls. Please see below for instructions on how to receive CE.

Activity Specific Objectives

At the conclusion of this COCA Call, the participant will be able to accomplish the following:

  • Summarize the current status of influenza activity in the United States.
  • Discuss the circulating influenza strains seen this season and the implications for clinicians.
  • Describe antiviral treatment recommendations for patients with influenza.

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.


  • Alicia P. Budd, MPH
    Influenza Division
    National Center for Immunization and Respiratory Diseases
    Centers for Disease Control and Prevention
  • Angela Campbell, MD, MPH
    Medical Officer
    Influenza Division
    National Center for Immunization and Respiratory Diseases
    Centers for Disease Control and Prevention

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WC2922-012919 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “2018-2019 Influenza Season and Recommendations for Clinicians” – January 29, 2019, please visit TCEO and follow these 9 Simple Steps by March 4, 2019.

To receive continuing education (CE) for WD2922-012919 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “2018-2019 Influenza Season and Recommendations for Clinicians” – January 29, 2019, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by March 5, 2021.

January is Cervical Cancer Awareness Month

January is Cervical Cancer Awareness Month, which raises awareness about cervical cancer, and the Human Papillomavirus (HPV) vaccine that can help prevent it, and other cancers, from ever developing. Every year in the United States, HPV causes 10,800 cases of cervical cancer. Fortunately, HPV vaccination could prevent most of these cancers.

Learn more about HPV at:


Wegmans recalls cauliflower rice, stir-fry mixes due to E. coli concerns

Wegmans Food Markets is recalling cauliflower rice and vegetable stir-fry mixes sold this month in its stores in six states due to E. coli concerns. The move came just five days after a California farm involved in a recent E. coli outbreak that sickened nearly 60 people said it was recalling cauliflower and red and green lettuce. The Wegmans recall involves fresh Cauliflower Rice, Veggie Cauliflower Rice Blend and Stir-Fry Mix with Cauliflower sold between Dec. 7 and Dec. 18 at its 98 stores in New York, New Jersey, Pennsylvania, Maryland, Virginia and Massachusetts. All contain “use by” dates of Dec. 11 through Dec. 22, the company said. Learn more:

Surgeon General’s Advisory on E-cigarette Use Among Youth

Today U.S. Surgeon General Jerome Adams issued an Advisory on E-cigarette Use Among Youth at a press conference in Washington, D.C. The advisory, prompted by recent skyrocketing rates of e-cigarette use by our nation’s youth, will alert parents, teachers and health professionals about new types of e-cigarettes and the negative health consequences of youth use of these products.

E-cigarette use has recently surged among youth, fueled by new e-cigarette types that look like a USB flash drive and other shapes. One of the most commonly sold USB flash drive shaped e-cigarettes is JUUL, and other companies are now starting to sell e-cigarettes that look like USB flash drives. Most e-cigarettes contain nicotine, which can harm the developing adolescent brain.

The Surgeon General urges immediate action to protect our nation’s young people from the addiction to nicotine. The advisory encourages many different stakeholders to take action to protect our nation’s youth from this health risk, including parents, teachers, health professionals, and states, communities, tribes, and territories.

Learn more:

Update – Outbreak of E. coli Infections Linked to Romaine Lettuce

CDC, public health and regulatory officials in several states, Canada, and the FDA are investigating a multistate outbreak of Shiga toxin-producing Escherichia coli O157:H7 (E. coli O157:H7) infections. Read food safety alert.

As of December 6, 2018, 52 people infected with the outbreak strain of E. coli O157:H7 have been reported from 15 states. A list of the states and the number of cases in each can be found on the Map of Reported Cases page.

Illnesses started on dates ranging from October 5, 2018 to November 18, 2018. Ill people range in age from 1 to 84 years, with a median age of 30. Sixty-nine percent of ill people are female. Of 45 people with information available, 19 (42%) have been hospitalized, including two people who developed hemolytic uremic syndrome, a type of kidney failure. No deaths have been reported.

Illnesses that occurred after November 14, 2018, might not yet be reported due to the time it takes between when a person becomes ill with E. coliinfection and when the illness is reported. This takes an average of two to three weeks.

Investigation of the Outbreak

Epidemiologic and traceback evidence indicates that romaine lettuce from the Central Coastal growing regions of northern and central California is a likely source of this outbreak.

In interviews, ill people answered questions about the foods they ate and other exposures in the week before they became ill. Twenty-four (83%) of 29 people interviewed reported eating romaine lettuce. This percentage is significantly higher than results from a survey[PDF – 787 KB] of healthy people in which 47% reported eating romaine lettuce in the week before they were interviewed. Ill people reported eating different types of romaine lettuce in several restaurants and at home.

Preliminary traceback information from the FDA indicates that ill people in this outbreak ate romaine lettuce harvested from the Central Coastal growing regions of northern and central California. The specific California counties FDA identified in the traceback investigation are Monterey, San Benito, San Luis Obispo, Santa Barbara, Santa Cruz, and Ventura. At this time, no common grower, supplier, distributor, or brand of romaine lettuce has been identified.

The FDA, along with CDC and state partners, is investigating farms and cooling facilities in California that were identified in traceback. CDC collected samples of water to test for E. coli O157:H7; these test results are pending.

This investigation is ongoing, and CDC will provide more information as it becomes available.

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen. There is a remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury. Adverse effects that may be experienced are nausea, vomiting, epigastric pain, or more rarely, diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects. To date, Tris Pharma, Inc. has not received any reports of adverse events related to the lots of product that are the subject of this recall. Read More